DCF — WOODLAND HEIGHTS MED CENTER
Enterprise Value: $151.0M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$151.0M
Enterprise Value
$41.3M
PV of Cash Flows
$109.7M
PV of Terminal Value
$176.7M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $130.8M | $18.0M | 14.0% | $8.8M | $8.0M |
| Year 2 | $134.7M | $19.9M | 15.0% | $10.1M | $8.3M |
| Year 3 | $138.8M | $21.9M | 16.0% | $11.4M | $8.6M |
| Year 4 | $142.9M | $23.3M | 16.0% | $12.3M | $8.4M |
| Year 5 | $147.2M | $24.3M | 17.0% | $12.9M | $8.0M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $151.0M. Terminal value accounts for 73% of total EV — typical range (60-80%).
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$127.0M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base0.1326928349599073
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5